用于第二近红外窗口光声成像引导光热治疗的基于氮化钽的诊疗剂
Tantalum Nitride-Based Theranostic Agent for Photoacoustic Imaging-Guided Photothermal Therapy in the Second NIR Window.
作者信息
Yi Huixi, Yan Gaoyang, He Jinzhen, Zhuang Jiani, Jin Chengzhi, Zhang Dong-Yang
机构信息
Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, National Medical Products Administration, State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
出版信息
Nanomaterials (Basel). 2023 May 23;13(11):1708. doi: 10.3390/nano13111708.
Metal nitrides show excellent photothermal stability and conversion properties, which have the potential for photothermal therapy (PTT) for cancer. Photoacoustic imaging (PAI) is a new non-invasive and non-ionizing biomedical imaging method that can provide real-time guidance for precise cancer treatment. In this work, we develop polyvinylpyrrolidone-functionalized tantalum nitride nanoparticles (defined as TaN-PVP NPs) for PAI-guided PTT of cancer in the second near-infrared (NIR-II) window. The TaN-PVP NPs are obtained by ultrasonic crushing of massive tantalum nitride and further modification by PVP to obtain good dispersion in water. Due to their good absorbance in the NIR-II window, TaN-PVP NPs with good biocompatibility have obvious photothermal conversion performance, realizing efficient tumor elimination by PTT in the NIR-II window. Meanwhile, the excellent PAI and photothermal imaging (PTI) capabilities of TaN-PVP NPs are able to provide monitoring and guidance for the treatment process. These results indicate that TaN-PVP NPs are qualified for cancer photothermal theranostics.
金属氮化物具有优异的光热稳定性和转换性能,具有用于癌症光热治疗(PTT)的潜力。光声成像(PAI)是一种新型的非侵入性、非电离生物医学成像方法,可为精确癌症治疗提供实时指导。在这项工作中,我们开发了聚乙烯吡咯烷酮功能化的氮化钽纳米颗粒(定义为TaN-PVP NPs),用于在第二近红外(NIR-II)窗口进行PAI引导的癌症PTT。通过对块状氮化钽进行超声粉碎并进一步用PVP改性以在水中获得良好分散性,从而得到TaN-PVP NPs。由于它们在NIR-II窗口具有良好的吸光度,具有良好生物相容性的TaN-PVP NPs具有明显的光热转换性能,可在NIR-II窗口通过PTT实现高效肿瘤消除。同时,TaN-PVP NPs出色的PAI和光热成像(PTI)能力能够为治疗过程提供监测和指导。这些结果表明TaN-PVP NPs有资格用于癌症光热诊疗。